The purpose was to explore the diagnostic performance of combined physiological MRI of oxygen metabolism and neovascularization for glioma grading and characterization of isocitrate-dehydrogenase-1 (IDH1) gene mutation status. 83 patients with glioma WHO°II-IV were examined using vascular architecture mapping (VAM) and multiparametric quantitative BOLD (mp-qBOLD). Neovascularization correlated with increasing WHO° and microvessel type indicator (MTI) had the best diagnostic performance (AUC=0.782) for differentiation between glioma WHO°III and IV. IDH1-mutation was associated with significantly decreased cerebral metabolic rate of oxygen (CMRO2; P=0.037) in glioma WHO°II and significantly increased (P=0.013) MTI in glioma WHO°III, resulting in best diagnostic performance for IDH1-mutation detection.
This abstract and the presentation materials are available to members only; a login is required.